$42.61▲ 1.49 (3.62%)
Real-time prices · US MarketsClean balance sheet with low leverage (0.0× debt-to-equity).
cautious analyst consensus — few Buy ratings.
Quality
8
Health
9.7
Growth
6.2
Valuation
6
Sentiment
3.9
Analyst Target
$52.17
▲ +22.4% from current
Price Chart
Latest News
Fundamentals
Trailing P/E
9.7×
price-to-earnings
Forward P/E
32.6×
next 12 months est.
Market Cap
$1.2B
market capitalization
Div Yield
—
dividend yield
Profit Margin
14.3%
net profit margin
Gross Margin
85.8%
revenue minus COGS
ROE
18.4%
return on equity
Beta
0.73
vs S&P 500
52-Week Range
$39 — $147
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
What do analysts say about Inspire Medical Systems, Inc. right now?
Inspire Medical Systems, Inc.'s Q·Score is 7/10 (Bullish), reflecting its current fundamentals, analyst data, and valuation metrics. Clean balance sheet with low leverage (0.0× debt-to-equity). Key area to monitor: cautious analyst consensus — few Buy ratings. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for INSP?
The consensus price target for INSP is $52.17, based on ratings from 12 Wall Street analysts. This is 22.4% above the current price of $42.61. Price targets are forward-looking estimates and not guarantees of future performance.
Is INSP overvalued or undervalued?
Inspire Medical Systems, Inc. (INSP) scores in line with sector averages on valuation metrics. Its forward P/E ratio stands at 32.6×. The consensus analyst price target of $52.17 is 22% above the current price.
When does Inspire Medical Systems, Inc. report its next earnings?
Inspire Medical Systems, Inc.'s next earnings report is expected on approximately August 3, 2026.
What is Inspire Medical Systems, Inc.'s profit margin?
Inspire Medical Systems, Inc. has a net profit margin of 14.3%, which is solid for most industries. Its gross margin stands at 85.8%, indicating a high-margin business model.
Is Inspire Medical Systems, Inc.'s revenue growing?
Inspire Medical Systems, Inc. is reporting modest revenue growth of 1.6%.
How much debt does Inspire Medical Systems, Inc. have?
Inspire Medical Systems, Inc. has a debt-to-equity ratio of 0.04×, reflecting a very low debt-to-equity ratio, signalling a conservatively financed balance sheet. Its current ratio is 6.34×, indicating comfortable short-term liquidity.